MeSH tree: C01.925.928
Results from a clinical trial conducted by researchers at the National Institutes of Health (NIH) show that people with low-grade lymphomatoid granulomatosis who are treated with interferon alfa-2b, a type of immunotherapy, ...
Apr 4, 2023
0
49
A new combination drug treatment has shown promising results in patients with pan-refractory, recurrent/metastatic head and neck cancer, according to a study published today in the Journal of Clinical Oncology.
Mar 28, 2023
0
58
People with HIV have impaired immune responses to some pathogens and immunizations, and during the COVID-19 pandemic, they often experienced severe symptoms if infected with SARS‐CoV‐2. New research led by investigators at ...
Mar 9, 2023
0
75
New adoptive T cell therapies—in which T cells, the immune system's natural hunters patrolling the body for foreign adversaries, are retrieved from cancer-riddled patients, super-charged and amplified outside the body, and ...
Feb 10, 2023
0
124
Insufficient and disturbed sleep during the teenage years may heighten the subsequent risk of multiple sclerosis (MS), suggests a case-control study published online in the Journal of Neurology Neurosurgery & Psychiatry.
Jan 23, 2023
0
77
Research led by Virginia Commonwealth University's School of Medicine is providing new insight into how to best fight misinformation about vaccines and promote vaccination. By testing different science-based messages related ...
Dec 7, 2022
0
43
In most people, norovirus causes a few days of misery spent in the bathroom and then is quickly forgotten. Epstein-Barr virus can pass without any indication at all. And many people shrug off COVID-19.
Oct 31, 2022
0
57
The severity of children's atopic dermatitis (AD) in first grade may predict its persistence in sixth grade, according to a study published online Sept. 19 in the Journal of Dermatology.
Oct 24, 2022
0
41
Merkel cell carcinoma is a rare but aggressive form of skin cancer that has a high rate of metastasis and poor patient outcomes. The current standard of care for patients with recurrent, unresectable or metastatic disease ...
Sep 12, 2022
0
54
Multiple sclerosis used to be referred to as a "mystery illness" but now MS risk is less of a mystery as we gain a better understanding of its causes, according to the author of a Perspective published today by the Medical ...
Aug 16, 2022
0
65
